dc.creator | Palazón Carrión, Natalia | es |
dc.creator | Jiménez Cortegana, Carlos | es |
dc.creator | Sánchez-León, M. Luisa | es |
dc.creator | Henao Carrasco, Fernando Manuel | es |
dc.creator | Nogales-Fernández, Esteban | es |
dc.creator | Chiesa, Massimo | es |
dc.creator | Caballero, Rosalía | es |
dc.creator | Rojo, Federico | es |
dc.creator | Nieto García, María Adoración | es |
dc.creator | Sánchez Margalet, Víctor | es |
dc.creator | Cruz Merino, Luis de la | es |
dc.date.accessioned | 2024-03-06T17:20:37Z | |
dc.date.available | 2024-03-06T17:20:37Z | |
dc.date.issued | 2021 | |
dc.identifier.citation | Palazón Carrión, N., Jiménez Cortegana, C., Sánchez-León, M.L., Henao Carrasco, F.M., Nogales-Fernández, E., Chiesa, M.,...,Cruz Merino, L.d.l. (2021). Circulating immune biomarkers in peripheral blood correlate with clinical outcomes in advanced breast cancer. Scientific reports, 11 (1), 14426. https://doi.org/10.1038/s41598-021-93838-w. | |
dc.identifier.issn | 2045-2322 | es |
dc.identifier.uri | https://hdl.handle.net/11441/155906 | |
dc.description.abstract | Identifcation of the diferent elements intervening at the tumor microenvironment seems key
to explain clinical evolution in several tumor types. In this study, a set of immune biomarkers
(myeloid derived suppressor cells, regulatory T cells, and OX40+ and PD-1 +T lymphocytes counts)
in peripheral blood of patients diagnosed with advanced breast cancer were analyzed along of
frst line antineoplastic therapy. Subsequently, a comparison between groups with clinical beneft
versus progression of disease and with a healthy women cohort was executed. Results refected that
patients showed higher basal levels of myeloid derived suppressor cells (35.43, IR= 180.73 vs 17.53,
IR= 16.96 cells/μl; p= 0.001) and regulatory T cells (32.05, IR= 29.84 vs 22.61, IR= 13.57 cells/μl;
p= 0.001) in comparison with healthy women. Furthermore, an increase in the number of activated
T lymphocytes (expressing OX40), a decrease of immune inhibitory cells (MDSCs and Tregs) and
inhibited T lymphocytes (expressing PD-1) were observed along the treatment in patients with clinical
beneft (p≤ 0.001). The opposite trend was observed in the case of disease progression. These fndings
suggest that some critical immune elements can be easily detected and measured in peripheral blood,
which open a new opportunity for translational research, as they seem to be correlated with clinical
evolution, at least in ABC. | es |
dc.format | application/pdf | es |
dc.format.extent | 12 p. | es |
dc.language.iso | eng | es |
dc.publisher | Nature publishing group | es |
dc.relation.ispartof | Scientific reports, 11 (1), 14426. | |
dc.rights | Atribución 4.0 Internacional | * |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
dc.subject | Circulating immune biomarkers | es |
dc.subject | Peripheral blood | es |
dc.subject | Advanced breast cancer | es |
dc.subject | Breast cancer | es |
dc.subject | Cancer | es |
dc.title | Circulating immune biomarkers in peripheral blood correlate with clinical outcomes in advanced breast cancer | es |
dc.type | info:eu-repo/semantics/article | es |
dc.type.version | info:eu-repo/semantics/publishedVersion | es |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | es |
dc.contributor.affiliation | Universidad de Sevilla. Departamento de Bioquímica Médica y Biología Molecular e Inmunología | es |
dc.contributor.affiliation | Universidad de Sevilla. Departamento de Medicina | es |
dc.relation.publisherversion | https://www.nature.com/articles/s41598-021-93838-w | es |
dc.identifier.doi | 10.1038/s41598-021-93838-w | es |
dc.journaltitle | Scientific reports | es |
dc.publication.volumen | 11 | es |
dc.publication.issue | 1 | es |
dc.publication.initialPage | 14426 | es |